Winslow Evans & Crocker’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$4K Buy
76
+7
+10% +$291 ﹤0.01% 1120
2020
Q3
$3K Sell
69
-3
-4% -$96 ﹤0.01% 937
2020
Q2
$3K Hold
72
﹤0.01% 958
2020
Q1
$4K Sell
72
-22
-23% -$657 ﹤0.01% 870
2019
Q4
$6K Hold
94
﹤0.01% 916
2019
Q3
$6K Buy
94
+34
+57% +$1.3K ﹤0.01% 894
2019
Q2
$4K Sell
60
-10
-14% -$428 ﹤0.01% 978
2019
Q1
$4K Hold
70
﹤0.01% 986
2018
Q4
$4K Hold
70
﹤0.01% 926
2018
Q3
$6K Hold
70
﹤0.01% 882
2018
Q2
$4K Buy
70
+6
+9% +$317 ﹤0.01% 946
2018
Q1
$2.95K Hold
64
﹤0.01% 972
2017
Q4
$2.96K Hold
64
﹤0.01% 989
2017
Q3
$2.88K Sell
64
-146
-70% -$6.23K ﹤0.01% 989
2017
Q2
$8.25K Sell
210
-52
-20% -$1.97K ﹤0.01% 957
2017
Q1
$9.9K Hold
262
﹤0.01% 895
2016
Q4
$9.62K Sell
262
-24
-8% -$858 ﹤0.01% 888
2016
Q3
$9.88K Sell
286
-4
-1% -$140 ﹤0.01% 912
2016
Q2
$9.43K Hold
290
﹤0.01% 891
2016
Q1
$8.33K Hold
290
﹤0.01% 918
2015
Q4
$9.69K Hold
290
﹤0.01% 916
2015
Q3
$8.25K Sell
290
-50
-15% -$1.74K ﹤0.01% 927
2015
Q2
$13.7K Sell
340
-8
-2% -$359 ﹤0.01% 858
2015
Q1
$17.1K Sell
348
-124
-26% -$5.74K ﹤0.01% 763
2014
Q4
$21.5K Buy
+472
New +$18.5K 0.01% 712

Other funds holding AVNS

Winslow Evans & Crocker's AVNS Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Avanos Medical (AVNS) stake by 10% in Q4 2020, buying an estimated $291 and bringing the position to 76 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

Winslow Evans & Crocker first reported a position in AVNS in Q4 2014 and has held it in 25 quarters since. The position peaked at $21.5K in Q4 2014. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Winslow Evans & Crocker held 76 shares of Avanos Medical worth $4K as of Q4 2020.
  • Winslow Evans & Crocker bought 7 Avanos Medical shares in Q4 2020, an estimated $291.
  • Avanos Medical made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1120 holding.
  • Winslow Evans & Crocker first reported a position in Avanos Medical in Q4 2014 and has held it in 25 quarters since.
  • Winslow Evans & Crocker's Avanos Medical position peaked at $21.5K in Q4 2014.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.